GlassScriptPhysician profile
Seema Izfar
NPI 1982930335
$3,538.76
in general payments reported to CMS, 2019-2025
22 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $151 · 2021: $173 · 2022: $1,019 · 2023: $470 · 2024: $649 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,119.00 | 2021-2025 | Interstim, Gi Genius |
| Davol INC. | $699.78 | 2022-2024 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $300.59 | 2024 | |
| Biom'Up Sa | $299.81 | 2019 | |
| Biom'Up France Sas | $285.65 | 2020-2021 | |
| Medtronic USA, INC. | $260.80 | 2019-2020 | |
| Procept Biorobotics Corporation | $162.10 | 2025 | |
| Shionogi INC | $116.58 | 2019 | |
| Shire North American Group INC | $45.87 | 2019 | |
| Olympus America INC. | $34.08 | 2019 | |
| Intuitive Surgical, INC. | $25.00 | 2022 | |
| Mimedx Group, INC. | $24.65 | 2025 | |
| Integra Lifesciences Corporation | $22.96 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Acera Surgical, INC. | $21.65 | 2019 | |
| Abbvie INC. | $20.44 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.23 | 2019 | |
| Allergan, INC. | $17.24 | 2019 | |
| Acell, INC. | $16.24 | 2019 | |
| Coloplast Corp | $15.38 | 2022 | |
| Braintree Laboratories, INC. | $11.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.16 | 2019 | |
| Kerecis Limited | $7.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seema Izfar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.